Insiderkoll

SynAct Pharma AB

Position
Amount
2020-03-23SynAct Pharma ABTorbjörn BjerkeChairman of the BoardGift given
606 852
0SEK
0
2019-12-11
2020-03-18SynAct Pharma ABTerje KallandBoard of Director / StyrelseledamotSubscription
7 460
24,8SEK
185 008
2019-12-17
2020-03-17SynAct Pharma ABJohn HaurumBoard of Director / StyrelseledamotSubscription
7 460
24,8SEK
185 008
2020-01-19
2020-03-17SynAct Pharma ABThomas JonassenBoard of Director, Chief Strategy Officer / Styrelseledamot, CSOSubscription
7 460
24,8SEK
185 008
2019-12-01
2020-03-17SynAct Pharma ABTorbjörn BjerkeChairman of the Board/StyrelseordförandeSubscription
7 460
24,8SEK
185 008
2019-12-02
2020-03-17SynAct Pharma ABHenrik StageCFO/EkonomichefSubscription
7 460
24,8SEK
185 008
2019-12-01
2020-03-17SynAct Pharma ABJeppe ØvlesenCEO/Verkställande direktörSubscription
7 460
24,8SEK
185 008
2019-11-26
2019-11-27SynAct Pharma ABHenrik StageCFO / EkonomichefGift given
354 770
0SEK
0
2019-11-21
2019-11-27SynAct Pharma ABJeppe ØvlesenCEO / Verkställande direktörGift given
1 239 923
0SEK
0
2019-11-21
2018-05-09SynAct Pharma ABHenrik StageCFOAcquisition
20 202
9,9SEK
199 999,8
2018-05-02
2018-05-09SynAct Pharma ABThomas JonassenBoD and CSOAcquisition
30 302
9,9SEK
299 989,8
2018-05-07
2018-05-09SynAct Pharma ABThomas JonassenBoD and CSOGift given
2 040 008
0SEK
0
2018-05-02
2018-05-09SynAct Pharma ABHenrik StageCFOGift given
380 117
0SEK
0
2018-05-02
2017-10-06SynAct Pharma ABThomas JonassenCSO of SynAct Pharma ABAcquisition
9 200
6,9SEK
63 480
2017-10-02
2017-10-06SynAct Pharma ABGhita Ovlesen and Jeppe Ovlesen, owner of Quantass ApsCEO of SynAct Pharma ABAcquisition
9 071
7,105DKK
64 452,65
2017-10-02
2017-10-06SynAct Pharma ABHenrik StageCFO of SynAct Pharma ABAcquisition
7 000
6,895SEK
48 263,65
2017-10-02

Rows per page

Page 6 of 6
Twitter